Erin Kutz
Erin Kutz joins Xconomy with a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
Recent posts
-
There may be fervor around college basketball this month, but we’d like to think we drum up some pretty intense excitement around the mobile industry in March. Xconomy held its fourth... Read more »
-
Drug developers and a new health-focused video game startup made the New England life sciences news this week. Yes, you read that correctly.
—Akili Interactive Labs is hoping to be the first with... Read more »
-
Here’s a mix of New England tech and life sciences fundings we’ve tracked down over the last week.
—Apperian, a Boston-based company focused on enterprise mobile app management, has added $12.4 million in financing... Read more »
-
Each time new private investing data comes out, it seems like it’s another chance for California to show its dominance. That’s the case with the Halo Report, but this particular... Read more »
-
Partnership news, funding announcements, and an acquisition made up the New England deals news in the past week.
—Concert Pharmaceuticals sold a worldwide license of its psychiatric drug to California-based Avanir Pharmaceuticals... Read more »
-
It doesn’t take a neuroscientist to know that the past two New England Patriots vs. New York Giants Super Bowl games have been emotionally charged for fans.
But it might take one to... Read more »
-
Acquisitions, licensing deals, and companies emerging from stealth mode made up the New England life sciences news this week.
—My colleague Arlene took a closer look at the Alzheimer’s drugmaker Satori Pharmaceuticals, which... Read more »
-
Call it an embarrassment of riches. On Valentine’s Day (no coincidence) I published a roundup of 16 fashion tech startups with founders from Harvard Business School, and asked any entrepreneurs I may... Read more »
-
[Updated 2/29/12 at 10:45 am. See below] Life sciences, cleantech, mobile, and IT companies all had their fair share of deals announcements this week.
—Zipcar (NASDAQ: ZIP), the Cambridge,... Read more »
-
Not long ago I wrote about how luxury retailers’ increased willingness to sell online has helped foster a new generation of fashion-focused Internet startups (particularly from Harvard Business School).
But that categorical... Read more »
-
Drug development news was big this week in the Boston life sciences scene.
—Watertown-based Enanta Pharmaceuticals inked a lucrative partnership with Novartis to co-develop an experimental hepatitis C drug. The deal gives Enanta... Read more »
-
Lexington, MA-based FirstFuel Software announced today that it snapped up $10 million in Series A financing, led by Rockport Capital and joined by existing investors Nth Power and Battery Ventures. That comes... Read more »
-
Out-of-towner Amory Lovins drew a packed audience to Kendall Square last Thursday for a chat about his vision for our energy future—and how it can be achieved with better economics, no new... Read more »
-
Michael Duda uses the word fun quite a bit when talking about what he does. It’s not hard to see why. He’s co-founder of Consigliere Brand Capital, a New York-based investment and... Read more »
-
VC, cleantech, and biotech players populated the New England deal news this week.
—Cambridge, MA-based coal-to-natural-gas company GreatPoint Energy formed a $1.25 billion partnership with China Wanxiang Holdings, according to a ... Read more »
-
Clinical trial advances, new financing, and personnel moves made up the New England life sciences news this week.
—Biogen Idec (NASDAQ: [[ticker:BIIB]) scooped up Cambridge, MA-based drugmaker Stromedix for $75 million upfront... Read more »
-
Acquisitions are in the air in New England. Here’s what happened in the past week.
—Akamai Technologies (NASDAQ: AKAM), the Web content and delivery giant of Cambridge, MA, made a move to tackle... Read more »
-
When Harvard and startups are mentioned in the same sentence, it’s usually to talk about the undergrad dropouts who went on to start tech empires (think Bill and Mark). But Harvard... Read more »
-
New England drug developers made headlines this week with funding news.
—My San Diego colleague Bruce took a look at Applied Proteomics, the five-year-old biotech startup co-founded by MIT-trained computer scientist Danny Hillis... Read more »
-
She started her career as a management consultant, but Aubrie Pagano says she always knew she wanted to be an entrepreneur. And she was particularly energized by fashion.
So Pagano spent her free... Read more »
